Results 71 to 80 of about 23,625 (204)

DETERMINATION OF DILTIAZEM HCI AND DOTHIEPIN HCI THROUGH COMPLEX FORMATION

open access: yesZagazig Journal of Pharmaceutical Sciences, 2006
Simple, sensitive and accurate spectrophotometric and atomic absorption spectrometric procedures were developed for the determination of both diltiazem and dothiepin hydrochlorides in pure forms and in pharmaceutical preparations.
Mervat Hosny , Heba El-Sayed
doaj   +1 more source

Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1250-1254, November 2026.
New Approach Methodologies (NAMs) represent a paradigm shift in drug development and regulatory science, offering human‐relevant alternatives to traditional preclinical models. This mini‐review highlights recent advances in NAM development, validation, and regulatory application from FDA's Division of Applied Regulatory Science (DARS).
Ksenia Blinova   +9 more
wiley   +1 more source

Diltiazem for control of ventricular response

open access: yes, 1987
Diltiazem, a calcium channel antagonist with negative dromotropic properties, was given to 16 patients with chronic atrial fibrillation who had poor exercise rate control on a regimen of digoxin alone.
Katz, R. J., Steinberg, J. S.
core  

Regional coronary hemodynamic effects of diltiazem in man

open access: yes, 1988
We evaluated the changes in regional coronary hemodynamics induced by diltiazem, 0.25 mg/kg intravenously, in nine patients with 75% to 90% diameter stenosis of the left anterior descending coronary artery (LAD) (group 1) and in 10 patients with 100 ...
Farese N   +17 more
core   +1 more source

Diltiazem and granulomatous hepatitis.

open access: yes, 1985
A case of granulomatous hepatitis proven by biopsy and related to diltiazem use is described. Clinicians should be alert to the possible presence of this complication in patients who develop fever, laboratory abnormalities, or clinical evidence of ...
Matulewicz, T J   +2 more
core   +1 more source

Drug–Drug Interactions of Cenobamate With Medications: Dose‐Dependent Induction/Inhibition and Clinical Implications

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 11, November 2026.
ABSTRACT Cenobamate causes dose‐dependent cytochrome P450 (CYP)2B6 and CYP3A4 induction and CYP2C19 inhibition, raising concern over multi‐pathway drug–drug interactions (DDIs) in patients with epilepsy treated with cardiovascular co‐medications. We developed a physiologically based pharmacokinetic (PBPK) model for cenobamate and verified it using ...
Hiroyuki Ichida   +7 more
wiley   +1 more source

Calcium channel block by Diltiazem [PDF]

open access: yes, 2011
Der Einstrom von Calcium durch spannungsabhängige Cav1.2 Kanäle reguliert Erregung und Kontraktilität der Muskulatur, die Freisetzung von Hormonen und Neurotransmittern aus sekretorischen Zellen oder Nervenzellen und eine Vielzahl anderer zellulärer ...
Shabbir, Waheed
core  

Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients with Severe Preeclampsia: A Randomized, Single-Blind, Controlled Trial

open access: yesInternational Journal of Hypertension, 2020
Background. Postpartum preeclampsia is a serious disease related to high blood pressure that occurs commonly within the first six days after delivery. Objective.
Gilberto Arias-Hernández   +3 more
doaj   +1 more source

Metabolic Stress Shifts the Function of KCa3.1 Channels in Pancreatic Beta Cells From a Regulator of Membrane Potential to a Proapoptotic Factor

open access: yesArchiv der Pharmazie, Volume 359, Issue 10, October 2026.
KATP and KCa3.1 channels are the main components of the regulatory K+ current “Kslow” of pancreatic beta cells. In a diabetogenic environment, the KCa3.1 component of Kslow decreases, and the channel is dysregulated. A targeted pharmacological approach reveals that KCa3.1 channels are functional in mitochondria.
Jurek Hense   +4 more
wiley   +1 more source

Scale factors used to simulate pharmacological manipulation with Diltiazem.

open access: yes, 2019
Scale factors used to simulate pharmacological manipulation with Diltiazem.
Brian D. Guth (7359392)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy